PAVmed
PAVM
15 hedge funds and large institutions have $3.2M invested in PAVmed in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
25% more capital invested
Capital invested by funds: $2.55M → $3.2M (+$644K)
0% more funds holding
Funds holding: 15 → 15 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$46.2K |
| 2 |
VF
Virtu Financial
New York
|
+$19.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.9K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$15.8K |
| 5 |
BlackRock
New York
|
+$13.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$26K |
| 2 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$11K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$6K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.92K |
PAVM Hedge Fund Activity: Q4 2019 in Review
15 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2019, worth a combined $3.2M — up 25% from $2.55M a quarter earlier.
Fund positioning in PAVM was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $46.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26K sold.
- 15 institutional investors held PAVmed (PAVM) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $3.2M of PAVmed stock for Q4 2019, up 25% quarter-over-quarter.
- 4 funds opened new PAVmed positions in Q4 2019 and 4 closed out, a net change of 0 holders.
- The largest PAVmed buyer in Q4 2019 was Levin Capital Strategies, an estimated $46.2K added.
- The largest PAVmed seller in Q4 2019 was Citadel Advisors, an estimated $26K sold.
Based on aggregated 13F filings for Q4 2019.